Antibody Analytics logo — We provide drug developers with data of outstanding quality...

Antibody Analytics

We provide drug developers with data of outstanding quality to give them confidence to expedite new healthcare solutions

Founded 2015 United Kingdom Motherwell, United Kingdom 83 employees Private Equity Logistics and Delivery

General Information

Company Name Antibody Analytics
Founded Year 2015
Location United Kingdom Motherwell, United Kingdom +1
Employees 83
Industries Logistics and Delivery
Funding Stage Private Equity
Social

Get notified when Antibody Analytics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Antibody Analytics

Antibody Analytics is a biotech startup dedicated to enhancing drug development through expert bioanalytical testing and adaptive solutions for complex molecular challenges. The company's slogan, "Enhancing drug development with expert bioanalytical testing and adaptive solutions for complex molecular challenges," reflects their commitment to providing tailored solutions for the pharmaceutical industry. Founded in 2015, Antibody Analytics specializes in bioanalytical testing, a critical aspect of drug development programs. Their expertise lies in collaborating with clients on intricate molecules, understanding the scientific nuances of assays, and navigating the regulatory landscape. The company's last investment, a Private Equity Round, took place on 02 November 2023, with NorthEdge Capital as the investor. This backing signifies confidence in the potential of Antibody Analytics and underscores their value proposition in the biotech ecosystem. The company's strategic focus on bioanalytical testing and strong investor support position them as a compelling player in the drug development industry's continued growth and innovation.

Taxonomy: Bioanalytical testing, Drug development, Expertise, Molecular challenges, Adaptive solutions, Regulatory framework, Complex molecules, Assay science, Reliable assays, Expedited drug development, Partnership, Flexibility, Scientific understanding

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 1
Investor
02 Nov 2023

Antibody Analytics Alternatives & Competitors

Antibody Analytics vs
ProfoundBio
ProfoundBio United States

An oncology biotherapeutics company

Series B
8 employees
Biotechnology, Health and Wellness
Antibody Analytics vs
Eurofins DiscoverX
Eurofins DiscoverX United States

The Eurofins Discovery Products Company

Series Unknown
121 employees
Biotechnology, Manufacturing
Antibody Analytics vs

Details Make Our Profession.

Undisclosed
21 employees
Biotechnology, Clean Energy

FAQ About Antibody Analytics

We provide drug developers with data of outstanding quality to give them confidence to expedite new healthcare solutions
Antibody Analytics was founded in 2015.
Antibody Analytics is headquartered in Motherwell, United Kingdom.
Antibody Analytics operates in the following industries: Logistics and Delivery.
Antibody Analytics has approximately 83 employees.
Antibody Analytics has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to Antibody Analytics include ProfoundBio, Eurofins DiscoverX, Leadgene Biomedical, Inc., Grid Therapeutics, ZabBio, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antibody Analytics and ProfoundBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Antibody Analytics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes